TRAF5 and diffuse large B-cell lymphoma: In Compagno group's study [8], the activation of NF-κB in DLBCL was aroused by multiple genes, including TRAF5, NF-κB inhibitor alpha (NFKBIA) and TNF receptor-associated factor 3 (TRAF3).